Preoperative staging of endometrial cancer using TVS, MRI, and hysteroscopy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 5, 2013, Pages 536-545

  Ørtoft, Gitte ^a   Dueholm, Margit ^a   Mathiesen, Ole ^a   Hansen, Estrid S ^a   Lundorf, Erik ^a   Møller, Charlotte ^a   Marinovskij, Edvard ^a   Petersen, Lone K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endometrial biopsy; endometrial cancer; hysteroscopy; magnetic resonance imaging; myometrial invasion; preoperative staging; tumor grade TVS

Indexed keywords

ANTIBIOTIC AGENT; GADOTERATE MEGLUMINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; HYSTEROSCOPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTEROSCOPY; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; PREOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84876487610     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12103     Document Type: Article

References (30)

1. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N, Manuzzi L, et al. Controversies in surgical staging of endometrial cancer. Obstet Gynecol Int. 2010; 2010: 181963.
2. Chan JK, Kapp DS,. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 2007; 8: 831-41.
3. Holland CM,. The role of radical surgery in carcinoma of the endometrium. Clin Oncol. 2008; 20: 448-56.
4. Poulsen HK, Jacobsen M, Bertelsen K, Andersen JE, Ahrons S, Bock JE, et al. Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group. Int J Gynecol Cancer. 1996; 6: 38-43.
5. Bertelsen K, Ortoft G, Hansen ES,. Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy. Int J Gynecol Cancer. 2011; 21: 1191-9.
6. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial-PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000; 355: 1404-11.
7. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373: 137-46.
8. Alders J, Abeler J, Kolstad P, Onsrud M,. Postoperative external irradiation and prognosis parameters in stage I endometrial carcinoma: clinical and histopathogenic study of 540 patients. Obstet Gynecol. 1980; 56: 419-26.
9. Hogberg T, Rosenberg P, Kristensen G, de Oliveira CF, de Pont Christensen R, Sorbe B, et al. A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSOG-EC-9501/Eortec 55991)). J Clin Oncol. 2007; 25: 5503.
10. Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer. 2006; 95: 266-71.
11. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol. 2008; 108: 226-33.
12. Bernardini MQ, May T, Khalifa MA, Bland AE, Nofech-Mozes S, Berchuck A, et al. Evaluation of two management strategies for preoperative grade 1 endometrial cancer. Obstet Gynecol. 2009; 114: 7-15.
13. Traen K, Hølund B, Mogensen O,. Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta Obstet Gynecol Scand. 2007; 86: 739-41.
14. Franchi M, Ghezzi F, Melpignano M, Cherchi PL, Scarabelli C, Apolloni C, Zanaboni F,. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol. 2010; 76: 357-61.
15. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F,. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002; 186: 409-15.
16. Celik C, Ozdemir S, Esen H, Balci O, Ylmaz O,. The clinical value of preoperative and intraoperative assessments in the management of endometrial cancer. Int J Gynecol Cancer. 2010; 20: 358-62.
17. Ozdemir S, Celik C, Emlik D, Kiresi D, Esen H,. Assessment of myometrial invasion in endometrial cancer by transvaginal sonography, Doppler ultrasonography, magnetic resonance imaging and frozen section. Int J Gynecol Cancer. 2009; 19: 1085-90.
18. Karlsson B, Norström A, Granberg S, Wikland M,. The use of endovaginal ultrasound to diagnose invasion of the endometrial carcinoma. Ultrasound Obstet Gynecol. 1992; 2: 35-9.
19. Savelli L, Ceccarini M, Ludovisi M, Fruscella E, De Iaco PA, Salizzoni E, et al. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008; 31: 560-6.
20. Rieck GC, Bulman J, Whitaker R, Leeson SC,. A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma. J Obstet Gynecol. 2005; 25: 765-8.
21. Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer. 2007; 17: 188-96.
22. McComiskey MH, McCluggage WG, Grey A, Harley I, Dobbs S, Nagar HA,. Diagnostic accuracy of magnetic resonance imaging in endometrial cancer. Int J Gynecol Cancer. 2012; 22: 1020-5.
23. Duncan KA, Drinkwater KJ, Frost C, Remedios D, Barter S,. Staging cancer of the uterus: a national audit of MRI accuracy. Clin Radiol. 2012; 67: 523-30.
24. Cutillo G, Cignini P, Visca P, Vizza E, Sbiroli C,. Endometrial biopsy by means of the hysteroscopic resectoscope for the evaluation of tumor differentiation in endometrial cancer: a pilot study. Eur J Surg Oncol. 2007; 33: 907-10.
25. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ,. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol. 1995; 86: 38-42.
26. Suh-Burgmann E, Hung Y, Armstrong M,. Complex atypical endometrial hyperplasia. The risk of unrecognized adenocarcinoma and value of preoperative dilation and cvurettage. Obstet Gynecol. 2009; 114: 523-9.
27. de la Cuesta SR, Espinosa JA, Crespo E, Granizo JJ, Rivas F,. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2004; 10: 211-5.
28. Cicinelli E, Tinelli R, Colafiglio G, Fortunato F, Fusco A, Mastrolia S, et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause. 2010; 17: 511-5.
29. Takac I, Zegura B,. Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer. Gynecol Oncol. 2007; 107: 94-8.
30. FIGO Committee on gynecologic oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105: 103-4.